Regeneron Pharmaceuticals REGN
NASDAQ REGN
$843.46 -8.57 (-1.01%)
As of: Sep 3, 2026 · 3:59 PM EDT

Regeneron Pharmaceuticals (REGN) Price to Sales (2009 - 2026)

Analysis

Regeneron Pharmaceuticals (REGN) Price to Sales (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Incyte 25.65 Bn 21.11 Bn 1.57 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.94
Mar 31, 2026 22.29
Dec 31, 2025 20.79
Sep 30, 2025 15.52
Jun 30, 2025 15.01
Mar 31, 2025 22.34
Dec 31, 2024 20.28
Sep 30, 2024 30.54
Jun 30, 2024 32.03
Mar 31, 2024 32.99
Dec 31, 2023 27.29
Sep 30, 2023 26.02
Jun 30, 2023 24.34
Mar 31, 2023 27.83
Dec 31, 2022 772.72
Sep 30, 2022 25.08
Jun 30, 2022 26.54
Mar 31, 2022 1,782.37
Dec 31, 2021 16.10
Sep 30, 2021 21.84